S100A13 and pulmonary fibrosis: S100A3 and S100A13 mutations are particularly relevant in the context of familial early-onset pulmonary fibrosis (PF), with our research showing that these mutations disrupt key cellular processes that contribute to fibrosis (Figure 3).